All Insights
Regulatory GuidePortugal

INFARMED Portugal Drug Approval: Sourcing Indian Generics for Iberian Importers

15 November 2026By Tuli Enterprise Export Team

How Indian generic exporters and Portuguese importers navigate INFARMED authorisation, EU import rules, dossiers and labelling.

Understanding the Portuguese Market

Portugal is a regulated European Union market with a steady demand for generic medicines, driven by public hospitals, community pharmacies and policies that encourage generic prescribing. For buyers searching for ways to import medicines from India to Portugal, the first thing to understand is that India-made finished products can enter the market, but only through an EU-compliant legal structure. The national regulator is INFARMED, I.P. (Autoridade Nacional do Medicamento e Produtos de Saúde), which oversees marketing authorisations, manufacturing and import licences, wholesale distribution, pharmacovigilance and market surveillance.

This guide outlines the framework in general terms so importers and distributors can plan sourcing. Requirements change, so always confirm current rules directly with INFARMED or a regulatory consultant before committing to a purchase.

The Core Principle: Authorised Product, Authorised Operators

Two things must be in place for a generic medicine to be legally supplied in Portugal:

  • A valid marketing authorisation (AIM) for the specific product, held by a Marketing Authorisation Holder (MAH) established in the European Economic Area.
  • Licensed operators in the supply chain: an importer with the appropriate manufacturing/import authorisation, and wholesale distributors holding a distribution authorisation issued by INFARMED.

An overseas exporter, including a merchant exporter such as Tuli Enterprise, does not itself become the MAH or importer of record. Instead, the exporter supplies product and documentation to a Portuguese or EU-based partner who holds the authorisation and licences.

Marketing Authorisation Routes

Generic products can generally reach the Portuguese market through one of several procedures:

  1. National procedure – an application submitted directly to INFARMED for Portugal only.
  2. Mutual recognition or decentralised procedure – used when a product is to be authorised in several EU member states, with Portugal as a concerned state.
  3. Centralised procedure – coordinated at EU level for certain product categories.

Many importers prefer to source products that already hold an EU authorisation, or to partner with an MAH who is willing to add an Indian manufacturing source through a variation. Starting a new application requires a full dossier and a defined timeline that depends on the procedure and on regulator workload; we do not quote fixed durations, and buyers should verify current expectations with INFARMED.

Dossier Requirements for Generics

Applications are submitted in the EU Common Technical Document (CTD) format. A generic dossier typically includes:

  • Module 1: administrative information, application forms, product information, and Portuguese-language texts.
  • Module 2: quality, non-clinical and clinical overviews and summaries.
  • Module 3: quality data covering drug substance, drug product, specifications, validation and stability.
  • Modules 4 and 5: non-clinical and clinical information, usually including bioequivalence data against a reference product where applicable.

Stability data should follow ICH guidelines and be appropriate for the climatic zone relevant to Portugal. Active substance information may be supplied through an ASMF or a certificate of suitability, depending on the source. Tuli Enterprise coordinates CTD dossier support, stability data and manufacturing partner coordination through its Indian manufacturing network, which helps importers who need technical documents from the source facility.

Manufacturing and Quality Expectations

The EU requires that medicines be manufactured to EU-equivalent good manufacturing practice. For products made outside the EU, the importing entity must hold an import authorisation, and every batch must undergo quality control testing in the EU/EEA and certification by a Qualified Person (QP) before release to the market. In practice this means:

  • The manufacturing site should be able to demonstrate GMP compliance acceptable to EU authorities, which may involve inspection or documented evidence requested by the regulator.
  • The Portuguese importer will perform or arrange batch testing and QP release, so analytical methods must be transferable and the Certificate of Analysis (CoA) clear and complete.
  • Active substance suppliers must also be traceable and compliant.

Tuli Enterprise works with GMP-certified manufacturing partners and can supply a COPP, CoA, Free Sale Certificate and stability documentation for review. Buyers should still carry out their own supplier qualification and audits as required by their licences.

Labelling and Packaging

Packaging for Portugal must meet EU labelling rules and national requirements. Key points include:

  • Package leaflet and labelling in Portuguese, consistent with the approved product information.
  • Braille on the outer pack where required, plus the safety features and serialisation required under EU falsified medicines rules.
  • Batch number, expiry date and the MAH details as authorised.

Because artwork and serialisation must be correct before commercial supply, agree packaging specifications with your manufacturing partner early. Smaller or private-label programmes may be handled via contract and third-party manufacturing.

Pricing, Reimbursement and Hospital Channels

Medicine prices and reimbursement in Portugal are regulated. Generic suppliers must consider the national pricing framework and reference pricing before committing to cost structures. Public hospitals purchase through centralised and institutional procedures, so buyers targeting tenders should confirm eligibility, documentation and pricing rules with the relevant bodies. We do not claim any tender outcomes; our role is to supply compliant, well-documented products to your licensed organisation.

Practical Steps for Importers and Distributors

  1. Define the product list. Choose molecules, strengths and pack sizes, and check existing authorisations in Portugal. Browse our product catalogue or filter by therapeutic category.
  2. Confirm your licensing. Make sure the importer and distributor hold the required INFARMED authorisations and QP arrangements.
  3. Identify the MAH. Either use an existing MAH or establish a registration strategy for a new application or variation.
  4. Request technical documents. Ask for the CTD dossier, CoA, stability data, COPP and Free Sale Certificate for evaluation.
  5. Approve artwork and serialisation. Align labelling, leaflets and anti-falsification features before production.
  6. Plan logistics. Confirm Incoterms, temperature requirements, import documentation and EU release timing.

MOQ and Lead Time

Minimum order quantities and lead times depend on the product, packaging format, dossier readiness and whether custom artwork is needed. Ready-to-ship items with existing authorisation-compatible packaging are usually faster than new, custom-labelled programmes. We provide precise MOQ and lead time figures in each written quotation rather than generic estimates.

Why Work with an Indian Merchant Exporter

Tuli Enterprise, based in New Delhi, supplies pharmaceuticals to buyers in more than 95 countries across Africa, Southeast Asia, the Middle East, Latin America, CIS and Europe, and is a member of PHARMEXCIL and FPME. We consolidate sourcing from multiple manufacturing partners, prepare export documentation and respond to technical queries from regulatory teams. You can also review our experience in other regions on the countries we serve page.

Request a Quote

If you are planning to import medicines from India to Portugal, send us your product list, target strengths, pack formats and licensing details through our contact form, message us on WhatsApp at wa.me/919654308142, or email [email protected]. Our team will respond with documentation availability, MOQ and lead time for your shortlist.

Need a supplier for this market?

Tuli Enterprise supplies WHO-GMP certified generics and nutraceuticals worldwide with full registration and export documentation.

Request a Quote